PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes.
暂无分享,去创建一个
Philippe Lambin | Cary Dehing-Oberije | Geert Bosmans | André Dekker | Dirk De Ruysscher | Liesbeth Boersma | Angela van Baardwijk | Søren M Bentzen | Ruud Houben | P. Lambin | A. Dekker | L. Boersma | D. de Ruysscher | C. Dehing-Oberije | M. Hochstenbag | G. Bosmans | A. V. van Baardwijk | S. Bentzen | R. V. van Suylen | J. Buijsen | Jeroen Buijsen | Stofferinus Wanders | Monique Hochstenbag | R. Houben | M. V. van Kroonenburgh | Robert-Jan van Suylen | Marinus van Kroonenburgh | S. Wanders | Cary Dehing-Oberije
[1] Liesbeth Boersma,et al. Feasibility of pathology-correlated lung imaging for accurate target definition of lung tumors. , 2007, International journal of radiation oncology, biology, physics.
[2] K. Nackaerts,et al. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lu , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] Philippe Lambin,et al. The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning. , 2006, Cancer treatment reviews.
[4] Marcel van Herk,et al. Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis. , 2006, International Journal of Radiation Oncology, Biology, Physics.
[5] A. Riegel,et al. Variability of gross tumor volume delineation in head-and-neck cancer using CT and PET/CT fusion. , 2005, International journal of radiation oncology, biology, physics.
[6] S. Rafla,et al. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer. , 2005, International journal of radiation oncology, biology, physics.
[7] Marcel van Herk,et al. Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: a 'Big Brother' evaluation. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[8] Jean-François Daisne,et al. Inter-observer variability in the delineation of pharyngo-laryngeal tumor, parotid glands and cervical spinal cord: comparison between CT-scan and MRI. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[9] R. T. Ten Haken,et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study. , 2005, International journal of radiation oncology, biology, physics.
[10] L. Boersma,et al. 142 Feasibility of pathology-correlated lung imaging for accurate target definition of lung tumors , 2005 .
[11] C. Rübe,et al. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[12] Philippe Lambin,et al. Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: a prospective clinical study. , 2005, International journal of radiation oncology, biology, physics.
[13] Cyrill Burger,et al. Automated functional image-guided radiation treatment planning for rectal cancer. , 2005, International journal of radiation oncology, biology, physics.
[14] Philippe Lambin,et al. Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: a planning study. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[15] Sadek Nehmeh,et al. Does registration of PET and planning CT images decrease interobserver and intraobserver variation in delineating tumor volumes for non-small-cell lung cancer? , 2005, International journal of radiation oncology, biology, physics.
[16] T. Stijnen,et al. Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer. , 2005, The Annals of thoracic surgery.
[17] Jean-François Daisne,et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. , 2004, Radiology.
[18] S. Bujenovic. The role of positron emission tomography in radiation treatment planning. , 2004, Seminars in nuclear medicine.
[19] B. Loo,et al. A method of target definition in PET-based radiotherapy planning , 2004 .
[20] J. Thie. Understanding the standardized uptake value, its methods, and implications for usage. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] Lei Dong,et al. Evaluation of a contour-alignment technique for CT-guided prostate radiotherapy: an intra- and interobserver study. , 2004, International journal of radiation oncology, biology, physics.
[22] Sasa Mutic,et al. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. , 2004, International journal of radiation oncology, biology, physics.
[23] Søren M Bentzen,et al. High-tech in radiation oncology: should there be a ceiling? , 2004, International journal of radiation oncology, biology, physics.
[24] Anne Bol,et al. Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[25] Cyrill Burger,et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. , 2003, International journal of radiation oncology, biology, physics.
[26] T. Araki,et al. Concurrent two-dimensional radiotherapy and weekly docetaxel in the treatment of stage III non-small cell lung cancer: a good local response but no good survival due to radiation pneumonitis. , 2003, Lung cancer.
[27] G. V. von Schulthess,et al. Impact of whole-body 18F-FDG PET on staging and managing patients for radiation therapy. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[28] R. Fisher,et al. Measurement of lung tumor volumes using three-dimensional computer planning software. , 2002, International journal of radiation oncology, biology, physics.
[29] Curtis B Caldwell,et al. The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study. , 2002, International journal of radiation oncology, biology, physics.
[30] Bernard Dubray,et al. Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[31] Arjan Bel,et al. Definition of gross tumor volume in lung cancer: inter-observer variability. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[32] S. Novello,et al. Is there a standard strategy in the management of locally advanced non-small cell lung cancer? , 2001, Lung cancer.
[33] C B Caldwell,et al. Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion. , 2001, International journal of radiation oncology, biology, physics.
[34] S. Dische,et al. Failure-specific prognostic factors after continuous hyperfractionated accelerated radiotherapy (CHART) or conventional radiotherapy in locally advanced non-small-cell lung cancer: A competing risks analysis , 2001, British Journal of Cancer.
[35] B J Mijnheer,et al. Variability in target volume delineation on CT scans of the breast. , 2001, International journal of radiation oncology, biology, physics.
[36] J. Luketich,et al. The role of positron emission tomography in evaluating mediastinal lymph node metastases in non-small-cell lung cancer. , 2001, Clinical lung cancer.
[37] V Kalff,et al. Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] A. E. Saarnak,et al. Inter-observer variation in delineation of bladder and rectum contours for brachytherapy of cervical cancer. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[39] Gerald J. Kutcher,et al. The impact of 18F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer , 2000 .
[40] W. Curran,et al. Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer : Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group , 2000 .
[41] S. Kudoh,et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[42] R K Ten Haken,et al. Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. , 1999, Lung cancer.
[43] K Okajima,et al. Differences in target outline delineation from CT scans of brain tumours using different methods and different observers. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[44] L. Stitt,et al. Variability of target volume delineation in cervical esophageal cancer. , 1998, International journal of radiation oncology, biology, physics.
[45] S U Berlangieri,et al. The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer. , 1998, Lung cancer.
[46] S M Larson,et al. Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding , 1997, Cancer.
[47] M. Martel,et al. Results of high-dose thoracic irradiation incorporating beam's eye view display in non-small cell lung cancer: a retrospective multivariate analysis. , 1993, International journal of radiation oncology, biology, physics.
[48] J. Hanley,et al. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. , 1983, Radiology.